CRYSTAL FORM OF (R)-N-METHYLNALTREXONE BROMIDE AND USES THEREOF
The present invention provides a new form of (R)-N-methylnaltrexone bromide, and compositions thereof, useful as a peripheral mu opiod receptor antagonist.
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
23.08.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention provides a new form of (R)-N-methylnaltrexone bromide, and compositions thereof, useful as a peripheral mu opiod receptor antagonist. |
---|---|
AbstractList | The present invention provides a new form of (R)-N-methylnaltrexone bromide, and compositions thereof, useful as a peripheral mu opiod receptor antagonist. |
Author | PEREZ, Julio AL-SHAREFFI, Kadum A BOYD, Thomas SMOLENSKAYA, Valeriya, N SHAH, Syed M |
Author_xml | – fullname: BOYD, Thomas – fullname: SMOLENSKAYA, Valeriya, N – fullname: AL-SHAREFFI, Kadum A – fullname: PEREZ, Julio – fullname: SHAH, Syed M |
BookMark | eNrjYmDJy89L5WSwdw6KDA5x9FFw8w_yVfB3U9AI0tT10_V1DfGI9PFz9AkJco3w93NVcAry9_V0cVVw9HNRCA12DVYI8XANcvV342FgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxkZmxqbmhk5GxkQoAQAn6SuR |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | KRISTALLFORM VON (R)-N-METHYLNALTREXONEBROMIDE UND VERWENDUNGEN DAVON FORME CRISTALLINE DE BROMURE DE (R)-N-METHYLNALTREXONE ET UTILISATIONS ASSOCIÉES |
ExternalDocumentID | EP3263571B2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP3263571B23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:00:34 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP3263571B23 |
Notes | Application Number: EP20170172002 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230823&DB=EPODOC&CC=EP&NR=3263571B2 |
ParticipantIDs | epo_espacenet_EP3263571B2 |
PublicationCentury | 2000 |
PublicationDate | 20230823 |
PublicationDateYYYYMMDD | 2023-08-23 |
PublicationDate_xml | – month: 08 year: 2023 text: 20230823 day: 23 |
PublicationDecade | 2020 |
PublicationYear | 2023 |
RelatedCompanies | Wyeth LLC (Formerly Known as Wyeth) Progenics Pharmaceuticals, Inc |
RelatedCompanies_xml | – name: Wyeth LLC (Formerly Known as Wyeth) – name: Progenics Pharmaceuticals, Inc |
Score | 3.4774792 |
Snippet | The present invention provides a new form of (R)-N-methylnaltrexone bromide, and compositions thereof, useful as a peripheral mu opiod receptor antagonist. |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | CRYSTAL FORM OF (R)-N-METHYLNALTREXONE BROMIDE AND USES THEREOF |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230823&DB=EPODOC&locale=&CC=EP&NR=3263571B2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-L8Ig9S9KHYNf1YH8pY25QqaztqJ93TaLoO9tINV_Hf91K26Yu-HQkclyN3l7vkfgF4MA2tv-AKl7lVYoJi6rps9UXdCreXleeLvGeIbuQwMoKJ9prpWQuWu16YBif0qwFHRIsq0N7rxl-vf4pYXvO2cvPMlzi0Gvip7Unb7FhtwFckz7HZOPZiV3JdpKQosakAXTF7DnrrA3GKFjD77N0RTSnr3xHFP4XDMTKr6jNolVUHjt3dx2sdOAq3991Ibk1vcw4DN5m-pcMRwbQtJLFPHpMnOZJDlgbTUTQcpQnL4ogRJ4nDF4-RYeSRCTpLkgYsYbF_AcRnqRvIKMlsv-oZG-9lppfQrlZVeQVE4bpJucapUaLt5So3TLVQFnNLLahW0KIL3T_ZXP8zdwMnQn2iWqrSW2jXH5_lHYbbmt83ivoGfAN90Q |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbokb87INZ9GER1n2wB0LY1mXo1pFZDDyRdYyEl0Fkxn_fdgH0Rd8ubXK5Xnp3vWvvV4AHy9S7C97mKrdzkaBYhqHaXVm3EtvLTtNF2jFlN3JEzWCsv0yMSQ2Wu16YCif0qwJHFBaVCXsvK3-9_iliedXbys0zX4qhVd9nPU_ZZsdaBb6ieE6PjGIvdhXXFZRCkx6WoCtWxxHe-sCS4Lzy5PTuyKaU9e-I4p_A4UgwK8pTqOVFExru7uO1JhxF2_tuQW5Nb3MGfTeZvrFBiETaFqHYR4_Jk0rViLBgGtJByBIyiSlBThJHQ4-gAfXQWDhLxAKSkNg_B-QT5gaqkGS2X_WMjPYy4wuoF6sivwTU5oaFuc6xmQvbSzVuWlrWXsxtLcN6hrMWtP5kc_XP3D00AhaFs3BIX6_hWKpSVk41fAP18uMzvxWht-R3ldK-AYaJgL4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CRYSTAL+FORM+OF+%28R%29-N-METHYLNALTREXONE+BROMIDE+AND+USES+THEREOF&rft.inventor=BOYD%2C+Thomas&rft.inventor=SMOLENSKAYA%2C+Valeriya%2C+N&rft.inventor=AL-SHAREFFI%2C+Kadum+A&rft.inventor=PEREZ%2C+Julio&rft.inventor=SHAH%2C+Syed+M&rft.date=2023-08-23&rft.externalDBID=B2&rft.externalDocID=EP3263571B2 |